Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-000643
Filing Date
2015-02-23
Accepted
2015-02-23 17:20:43
Documents
9
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q fuse10q_dec312014.htm 10-Q 655834
2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 SECTION 302 OF THE SARBANES-OXL ex31-1.htm EX-31.1 10883
3 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 SECTION 906 OF THE SARBANES-OXL ex32-1.htm EX-32.1 9540
  Complete submission text file 0001415889-15-000643.txt   4279123

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT drop-20141231.xml EX-101.INS 453463
5 XBRL TAXONOMY EXTENSION SCHEMA drop-20141231.xsd EX-101.SCH 29307
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drop-20141231_cal.xml EX-101.CAL 42763
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drop-20141231_def.xml EX-101.DEF 178851
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE drop-20141231_lab.xml EX-101.LAB 238480
9 XBRL TAXONOMY EXTENSION PRE SENTATION LINKBASE drop-20141231_pre.xml EX-101.PRE 232405
Mailing Address 6135 NW 167TH STREET #E21 MIAMI FL 33015
Business Address 6135 NW 167TH STREET #E21 MIAMI FL 33015 305-503-3873
Fuse Science, Inc. (Filer) CIK: 0000842722 (see all company filings)

EIN.: 870460247 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22991 | Film No.: 15640696
SIC: 2835 In Vitro & In Vivo Diagnostic Substances